MAPT and Alzheimer disease: All these evidences not only suggest that a decrement in the canonic signaling of the Wnt pathway not only plays a role in the neuronal damage observed in the AD, but also that this pathway could be the joining point of the pathologic processes generated by the Aβ and the tau protein, and thus a very significant target for AD treatment [97].